Investigación / Grupos de investigación

Grupo  2

Biología Molecular del VIH

Publicaciones (394)

  • Fernandez-Rodriguez, A; Berenguer, J; Jimenez-Sousa, MA; Garcia-Alvarez, M; Aldamiz-Echevarria, T; Pineda-Tenor, D; Diez, C; de la Barrera, J; Bellon, JM; Briz, V; Resino, S.

    Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients

    INFECTION GENETICS AND EVOLUTION. 2015; 36: 339-344 Nº de citas: 7 [doi:10.1016/j.meegid.2015.10.006]

  • Martinez-Bonet, M; Clemente, MI; Serramia, MJ; Munoz, E; Moreno, S; Munoz-Fernandez, MA.

    Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1

    Scientific Reports. 2015; 5: Nº de citas: 43 [doi:10.1038/srep16445]

  • Gomez, CE; Perdiguero, B; Garcia-Arriaza, J; Cepeda, V; Sanchez-Sorzano, CO; Mothe, B; Jimenez, JL; Munoz-Fernandez, MA; Gatell, JM; de Quiros, JCLB; Brander, C; Garcia, F; Esteban, M.

    A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART

    PLoS One. 2015; 10(11): Nº de citas: 19 [doi:10.1371/journal.pone.0141456]

  • Martinez-Bonet, M; Clemente, MI; Alvarez, S; Diaz, L; Garcia-Alonso, D; Munoz, E; Moreno, S; Munoz-Fernandez, MA.

    Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal

    ANTIVIRAL RESEARCH. 2015; 123: 163-171 Nº de citas: 10 [doi:10.1016/j.antiviral.2015.09.014]

  • Palladino, C; Gomez, MLN; Soler-Palacin, P; Gonzalez-Tome, MI; De Ory, SJ; Espiau, M; Hoyos, SP; Leon-Leal, JA; Mendez, M; Moreno-Perez, D; Guasch, CF; Sierra, AM; Guruceta, IP; Guillen, SM; Briz, V.

    Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice

    AIDS. 2015; 29(16): 2155-2159 Nº de citas: 4 [doi:10.1097/QAD.0000000000000819]

  • Sanchez-Rodriguez, J; Diaz, L; Galan, M; Maly, M; Gomez, R; de la Mata, FJ; Jimenez, JL; Munoz-Fernandez, MA.

    Anti-Human Immunodeficiency Virus Activity of Thiol-Ene Carbosilane Dendrimers and Their Potential Development as a Topical Microbicide

    J BIOMED NANOTECHNOL. 2015; 11(10): 1783-1798 Nº de citas: 18 [doi:10.1166/jbn.2015.2109]

  • Fuentes-Paniagua, E; Serramia, MJ; Sanchez-Nieves, J; Alvarez, S; Munoz-Fernandez, MA; Gomez, R; de la Mata, FJ.

    Fluorescein labelled cationic carbosilane dendritic systems for biological studies

    EUROPEAN POLYMER JOURNAL. 2015; 71: 61-72 Nº de citas: 23 [doi:10.1016/j.eurpolymj.2015.07.043]

  • Martinez-Bonet, M; Puertas, MC; Fortuny, C; Ouchi, D; Mellado, MJ; Rojo, P; Noguera-Julian, A; Munoz-Fernandez, MA; Martinez-Picado, J.

    Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy

    CLINICAL INFECTIOUS DISEASES. 2015; 61(7): 1169-1178 Nº de citas: 98 [doi:10.1093/cid/civ456]

  • Ferrando-Martinez, S; Ruiz-Mateos, E; Casazza, JP; de Pablo-Bernal, RS; Dominguez-Molina, B; Munoz-Fernandez, MA; Delgado, J; de la Rosa, R; Solana, R; Koup, RA; Leal, M.

    IFN gamma-TNF alpha(-)IL2(-)MIP1 alpha(-)CD107a(+)PRF1(+) CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2015; 70(10): 1210-1218 Nº de citas: 12 [doi:10.1093/gerona/glu171]

  • Moreno, S; Ortega, P; de la Mata, FJ; Ottaviani, MF; Cangiotti, M; Fattori, A; Munoz-Fernandez, MA; Gomez, R.

    Bifunctional Chelating Agents Based on Ionic Carbosilane Dendrons with DO3A at the Focal Point and Their Complexation Behavior with Copper(II)

    INORG CHEM. 2015; 54(18): 8943-8956 Nº de citas: 11 [doi:10.1021/acs.inorgchem.5b01047]

  • Klein, N; Palma, P; Luzuriaga, K; Pahwa, S; Nastouli, E; Gibb, DM; Rojo, P; Borkowsky, W; Bernardi, S; Zangari, P; Calvez, V; Compagnucci, A; Wahren, B; Foster, C; Munoz-Fernandez, MA; De Rossi, A; Ananworanich, J; Pillay, D; Giaquinto, C; Rossi, P.

    Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission

    LANCET INFECTIOUS DISEASES. 2015; 15(9): 1108-1114 Nº de citas: 36 [doi:10.1016/S1473-3099(15)00052-3]

  • Sepulveda-Crespo, D; Gomez, R; De La Mata, FJ; Jimenez, JL; Munoz-Fernandez, MA.

    Polyanionic carbosilane dendrimer-conjugated antiviral drugs as efficient microbicides: Recent trends and developments in HIV treatment/therapy

    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2015; 11(6): 1481-1498 Nº de citas: 63 [doi:10.1016/j.nano.2015.03.008]

  • Sepulveda-Crespo, D; Serramia, MJ; Tager, AM; Vrbanac, V; Gomez, R; De la Mata, FJ; Jimenez, JL; Munoz-Fernandez, MA.

    Prevention vaginally of HIV-1 transmission in humanized BLT mice and mode of antiviral action of polyanionic carbosilane dendrimer G2-S16

    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. 2015; 11(6): 1299-1308 Nº de citas: 57 [doi:10.1016/j.nano.2015.04.013]

  • Diaz, L; Martinez-Bonet, M; Sanchez, J; Fernandez-Pineda, A; Jimenez, JL; Munoz, E; Moreno, S; Alvarez, S; Munoz-Fernandez, MA.

    Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-kappa B-dependent mechanism

    Scientific Reports. 2015; 5: Nº de citas: 60 [doi:10.1038/srep12442]

  • Martinez-Bonet, M; Clemente, MI; Serramia, MJ; Moreno, S; Munoz, E; Munoz-Fernandez, MA.

    Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?

    Journal Of Virus Eradication. 2015; 1(3): 148-152 Nº de citas: 4

  • Vazquez-Castellanos, JF; Serrano-Villar, S; Latorre, A; Artacho, A; Ferrus, ML; Madrid, N; Vallejo, A; Sainz, T; Martinez-Botas, J; Ferrando-Martinez, S; Vera, M; Dronda, F; Leal, M; Del Romero, J; Moreno, S; Estrada, V; Gosalbes, MJ; Moya, A.

    Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

    MUCOSAL IMMUNOL. 2015; 8(4): 760-772 Nº de citas: 249 [doi:10.1038/mi.2014.107]

  • Garcia-Gallego, S; Diaz, L; Jimenez, JL; Gomez, R; de la Mata, FJ; Munoz-Fernandez, MA.

    HIV-1 antiviral behavior of anionic PPI metallo-dendrimers with EDA core

    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 2015; 98: 139-148 Nº de citas: 20 [doi:10.1016/j.ejmech.2015.05.026]

  • Sanchez, PR; de Mulder, M; Fernandez-Cooke, E; Prieto, L; Rojo, P; de Ory, SJ; Mellado, MJ; Navarro, M; Ramos, JT; Holguin, A; Spanish Natl AIDS Network CoRISPe.

    Clinical and virologic follow-up in perinatally HIV-1-infected children and adolescents in Madrid with triple-class antiretroviral drug-resistant viruses

    CLINICAL MICROBIOLOGY AND INFECTION. 2015; 21(6): Nº de citas: 11 [doi:10.1016/j.cmi.2015.02.003]